GAM Holding’s Five Prime Therapeutics FPRX Stock Holding History
Bought
Maintained
Sold
GAM Holding's FPRX Position: Q2 2021 in Review
GAM Holding sold out of Five Prime Therapeutics (FPRX) in Q2 2021, closing a stake of 16,800 shares — an estimated $633K sold.
GAM Holding first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $633K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- GAM Holding reported no remaining Five Prime Therapeutics position as of Q2 2021 after selling out during the quarter.
- GAM Holding sold 16,800 Five Prime Therapeutics shares in Q2 2021, an estimated $633K.
- GAM Holding first reported a position in Five Prime Therapeutics in Q1 2021 and held it in 1 quarter.
- GAM Holding's Five Prime Therapeutics position peaked at $633K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics as of Q2 2021.
Based on GAM Holding's 13F filing for Q2 2021, filed 9 Aug 2021.